Home » Authors » Karen Young

Articles by Karen Young

Hemosol’s Stock Falls 29 Percent After Hemolink Denial In Canada

March 22, 2002

Metabolex, Yamanouchi Enter Diabetes, Obesity Collaboration

March 21, 2002

Metabolex, Yamanouchi Enter Diabetes, Obesity Collaboration

March 21, 2002

AlgoRx Gets $25M In Series B, Buys PowderJect Technology

March 19, 2002

AlgoRx Gets $25M In Series B, Buys PowderJect Technology

March 19, 2002

ChemGenex Using Chemical Genomics To Move Drugs Along

March 18, 2002

ChemGenex Using Chemical Genomics To Move Drugs Along

March 18, 2002

PhageTech Raises $10M For Bacteriophage Genomics Work

March 15, 2002

PhageTech Raises $10M For Bacteriophage Genomics Work

March 15, 2002

Plexxikon’s Scaffold Discovery Factory Mines Protein Families

March 14, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...